-+ 0.00%
-+ 0.00%
-+ 0.00%

IDEAYA BIOSCIENCES, - TO INITIATE PHASE 3 TRIAL FOR IDE849 BY YEAR-END 2026 IN ES-SCLC

Reuters·08/31/2026 10:00:02

Please log in to view news